Bioventus Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	576.3	568.09	573.28	512.35	512.12	430.9
Revenue Growth (YoY)	1.52%	-0.91%	11.89%	0.04%	18.85%	34.17%
Cost of Revenue	180.43	179.93	185.05	184.15	181.04	128.19
Gross Profit	395.87	388.16	388.23	328.19	331.08	302.71
Selling, General & Admin	318.85	314.03	343.8	303.88	332.13	254.25
Research & Development	11.57	12.11	13.95	13.45	23.85	19.04
Other Operating Expenses	0.45	2.32	38.02	83.75	132.58	8.99
Total Operating Expenses	330.87	328.46	395.77	401.08	488.57	282.28
Operating Income	57.52	53.98	-15.2	-81.73	-167.23	12.06
Interest Expense	-23.3	-26.49	-38.79	-40.68	-12.02	-1.11
Other Non-Operating Income (Expense)	-16.19	-27.14	-38.79	-40.68	-12.02	-1.11
Total Non-Operating Income (Expense)	-39.5	-53.62	-77.58	-81.35	-24.04	-2.22
Pretax Income	33.64	25.71	-52.34	-121.11	-189.03	9.49
Provision for Income Taxes	-0.9	-1.57	-5.29	0.09	-44.37	-1.97
Net Income	28.48	22.73	-36.13	-156.23	-158.7	19.38
Minority Interest in Earnings	6.06	4.54	-10.92	-39.4	-54.69	-9.79
Earnings From Discontinued Operations	-	-	-	74.43	68.74	1.87
Net Income to Common	28.48	22.73	-36.13	-156.23	-158.7	19.38
Net Income Growth	-	-	-	-	-	18.06%
Shares Outstanding (Basic)	67	67	65	63	61	45
Shares Outstanding (Diluted)	69	69	65	63	61	45
Shares Change (YoY)	6.37%	6.77%	3.03%	2.05%	35.00%	-11.70%
EPS (Basic)	0.43	0.34	-0.56	-2.49	-2.59	-0.15
EPS (Diluted)	0.41	0.33	-0.56	-2.49	-2.59	-0.15
Shares Outstanding	67.64	67.1	65.76	63.27	62.06	59.55
Free Cash Flow	100.63	72.11	37.79	7.98	-15.02	9.47
Free Cash Flow Growth	39.55%	90.83%	373.43%	-	-	-82.85%
Free Cash Flow Per Share	1.45	1.05	0.59	0.13	-0.24	0.21
Gross Margin	68.69%	68.33%	67.72%	64.06%	64.65%	70.25%
Operating Margin	9.98%	9.50%	-2.65%	-15.95%	-32.66%	2.80%
Profit Margin	5.99%	9.60%	-16.41%	-61.84%	-69.91%	4.88%
FCF Margin	17.46%	12.69%	6.59%	1.56%	-2.93%	2.20%
EBITDA	103.87	100.99	34.36	-24.36	-111.84	46.94
EBITDA Margin	18.02%	17.78%	5.99%	-4.75%	-21.84%	10.89%
EBIT	57.52	53.98	-15.2	-81.73	-167.23	12.06
EBIT Margin	9.98%	9.50%	-2.65%	-15.95%	-32.66%	2.80%
Effective Tax Rate	-2.67%	-6.09%	10.11%	-0.07%	23.48%	-20.72%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q